RBC Capital analyst Leonid Timashev maintained a Buy rating on Edgewise Therapeutics (EWTX – Research Report) today and set a price target of ...
RBC Capital lowered the firm’s price target on Scotiabank (BNS) to C$81 from C$83 and keeps a Sector Perform rating on the shares.Discover the ...
RBC Capital Markets Global Financial Institutions Conference March 5, 2025 8:40 AM ETCompany ParticipantsPhil Thomas ...
Phil Thomas, Scotiabank's Group Head & Chief Risk Officer, will be participating in a fireside chat at the 2025 RBC Capital Markets Global Financial Institutions Conference in New York on March 5th, ...
In the second quarter of last year, RBC closed its deal to takeover HSBC Bank Canada, which was Canada’s seventh-largest ...
Three of Canada's big five lenders - Royal Bank of Canada, TD Bank and CIBC - on Thursday beat analyst expectations for ...
RBC Capital Markets Financial Institutions Conference March 4, 2025 8:00 AM ETCompany ParticipantsDave McKay - ...
RBC chief executive Dave McKay said Canada’s largest bank is preparing itself for a number of economic scenarios in the future due to the uncertainty linked to the tariffs.
Royal Bank of Canada beat estimates on higher results in its capital-markets and wealth-management divisions as both units ...
Phil Thomas, Scotiabank's Group Head & Chief Risk Officer, will be participating in a fireside chat at the 2025 RBC Capital Markets Global Financial Institutions Conference in New York on March 5th, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results